The gene for topoisomerase 11 has been isolated from genomic libraries of strain Kl of the human malarial parasite, Plasmodium falciparum. The sequence reveals an open reading frame of 4194 nucleotides which predicts a polypeptide of 1398 amino acids.
INTRODUCTION
Class II topoisomerases act by cleaving both strands of a DNA double helix, passing an unbroken DNA duplex through the gap produced before resealing the gap (Reviews see 1, 2) . As a result they are able to relieve torsional stresses and resolve topological constraints resulting from DNA replication. Topoisomerase II is known to be essential for the completion of chromosomal segregation at mitosis in yeast (3, 4) . It also appears to have important structural functions in the cell and is present throughout the cores of metaphase chromosomes of HeLa cells (5) . It is also present in meiotic chromosomes of chicken spermatocytes (6) and yeast (7) . The evidence suggests that it facilitates the EMBL accession no. X79345 condensation of yeast chromosomes in vivo (8) and chicken erythrocyte chromosomes in vitro (9) . Topoisomerase II associates with A/T-rich regions of the DNA and is found in preparations of the nuclear matrix and scaffold from chicken interphase nuclei (10) and in Drosophila (11) .
Topoisomerase II has been reported to be present at high levels in rapidly dividing cells (12, 13) and a number of anti-cancer drugs are known which act as topoisomerase II poisons (2) . These either intercalate into the DNA (e.g. m-AMSA and ellipticine) or they act by trapping the cleavable complex formed when each 5' terminus of the cleaved duplex becomes covalently linked to a molecule of the enzyme through a specific tyrosyl residue. This can be demonstrated by denaturing the complex with alkali or SDS whereupon protein-associated strand breaks appear. The trapped cleavable complexes are important contributors to cell death although precisely how they do this is not yet known and other cellular factors appear to be important (summarised in 1). The malarial parasite also divides rapidly after it enters the liver of the human host and after invasion of the erthyrocyte and attempts have been made to evaluate topoisomerase II poisons as potential antimalarial agents. Recently, interest has been focused on the 9-anilinoacridines which inhibit parasite metabolism (assayed by the incorporation of 3[H] hypoxanthine) and inhibit the decatenation of kinetoplast DNA by parasite extracts (14) . They are related structurally to the synthetic antimalarial, pyronaridine, which has already been studied extensively and has undergone clinical trials (15) . From a study of a number of 9-anilinoacridine derivatives it was concluded that hydrophilicity and a high ionisation constant are the important factors in determining activity. One of the active derivatives, 3,6 diamino-l'-amino-9-anilinoacridine, was highly selective in its action inhibiting malarial topoisomerase II activity at only 1/600th the level needed to inhibit mammalian topoisomerase II to the same extent.
As part of a wider program to evaluate the possibilities of using the parasite's DNA replication apparatus as a drug target we have set about isolating genes encoding its component polypeptides (16, 17, 18) . In the present report we describe the cloning and *To whom correspondence should be addressed 'Present address: Pharma Division, Preclinical Research, F.Hoffman-La Roche, CH5002 Basel, Switzerland . 1994 Oxford University Press the characterisation of the parasite gene for topoisomerase II. Work is currently underway to express the replication proteins heterologously to facilitate a detailed biochemical study of their properties.
MATERIALS AND METHODS
Parasite culture The Ki isolate of P.falciparum was used throughout (19) . It was cultured using the method of Trager and Jensen (20) as modified by Zolg et al. (21) . Cultures were synchronised as required using the method of Lambros and Vandenberg (22) .
DNA and RNA, isolation and blotting The methods used for nucleic acid isolation (23, 24, 25) , Southern (26) and Northern blotting (24) have already been fully reported elsewhere.
Isolation of the gene for topoisomerase H The sequence MIMTDQD is highly conserved in other eukaryotic topoisomerase II genes (27, 28, 29) . This was used to design the oligonucleotide probe ATGAT(A/C/T)ATGAC(A/G/C/T)GA-(C/T)CA(G/A)GA. The oligonucleotide was end labelled and used to probe a library of HindIu digested genomic parasite DNA constructed in XNM1 149. The first fragment to be isolated contained the 5' end of the gene and several hundred bases of 5' flanking DNA. Overlapping clones were obtained by screening genomic DNA libraries constructed in both XNM1 149 and Xgtl 1 with oligonucleotides, random labelled gene fragments or PCR products. The isolated fragments were subcloned into pUBS (30) or pUC19 (31) and sequenced on both strands by the Sanger and Coulson method (32) using Sequenase Kit version 2.0 (USB). The University of Wisconsin Genetics Computer Group (UWGCG) programs were used for sequence comparisons (33) .
Chromosome blots Established methods of pulsed field gel electrophoresis (16) were used to separate the chromosomes ofP.falciparum. Chromosome blots were prepared using Genescreen Plus membranes following the manufacturers' instructions.
Fusion protein constructs and antibody production The polymerase chain reaction was used to generate a product with a 5' BamHI recognition site. The product encoded the amino acids 6 to 144 inclusive of the Pftopoisomerase II predicted protein. This excludes two asparagine-rich inserts in the sequence (see Fig. 2 and Results). After cleavage with BamHl, the product was cloned into BamHI-and SmaI-digested pGEX2 in frame with the glutathione-S-transferase (GST) coding sequence (34) . Cloning junctions were confirmed by sequencing and the construct was transformed into E. coli BL21 cells for expression of the fusion product. The production of the fusion protein was inferred from the appearance, after induction with 0. lmM IPTG, of a major product of the anticipated size (42kDa) and the simultaneous disappearance of the band for GST (27kDa) on Coomassie Blue-stained SDS polyacrylamide gels. Approximately 20%g of insoluble fusion protein were emulsified in a mixture of 0. 15ml phosphate-buffered saline (PBS) and 0. 15ml complete Freunds adjuvant and used to immunise mice. The mice were boosted at two and four weeks after the initial immunisation. Individual sera prepared from these mice were used for immunofluorescence analysis of fixed, synchronised parasites and for western blot studies.
Serum preparation and Western blots
Before use, the mouse anti-Pftopoisomerase II serum was preadsorbed to GST bound to glutathione-agarose beads (Sigma) in order to remove antibodies recognising GST epitopes. Removal of these antibodies was verified by western blot analysis using purified GST. Western blot analysis was performed as described earlier (16) . Western blots of parasite extracts which had been reacted with mouse anti-Pftopoisomerase II serum were also analysed using the enhanced chemiluminescence system (ECL Amersham) incorporating anti-mouse IgG second antibody-linked horseradish peroxidase.
Immunofluorescence studies Acetone-fixed, parasitised erythrocytes from synchronous and asynchronous cultures were incubated with anti-Pftopoisomerase II serum for one hour at high humidity. After washing to remove unadsorbed antibodies the slides were treated with a fluorescin isothiocyanate (FITC) conjugate of goat anti-mouse IgG (Sigma). The slides were also counterstained with the nuclear-specific stain DAPI. Detection of intact parasites in samples taken soon after the synchronising treatment is often made difficult by cellular debris. To overcome this, synchronised material prepared as described above was also reacted with a polyclonal rabbit anti-P.falciparum parasitophorus vacuole membrane antibody and a rhodamine (RITC) conjugate of anti-rabbit IgG.
RESULTS
The structure of the topoisomerase II gene from P.faiciparum
The initial clone containing the 5' coding and flanking sequences of topoisomerase II was obtained as a 2.6kb fragment from a genomic HindIH DNA library in XNM1 149. Overlapping clones were isolated from a series of genomic DNA libraries. Their relationship to each other is given in the genomic map of the region (Fig. 1) the ATPase domain of the gyrase B subunit of Escherichia coli. The tyrosine residue at position 830 in Fig. 2 is conserved in all species so far studied. It corresponds to the residue forming the transient covalent link with the 5' ends of the severed DNA duplex (37) stabilising the 'gate' through which the unbroken duplex is passed. The predicted protein product of the Pftopoisomerase II gene differs from the sequences of all other species so far studied in its possession of two asparagine-rich insertions starting at position 267 (Fig. 2) . The presence of blocks of inserted amino acids, often containing repetitive sequences, and the occurrence of asparagine-rich regions is well documented for other Plasmodium proteins (38) and, in particular, we previously identified asparagine-rich regions in the predicted parasite DNA Polymerase a (18) . Here the two features coincide. The presence of nucleotides encoding this region in the mature message was demonstrated using cDNA-directed PCR with oligonucleotides flanking the insertions. Both cDNA and genomic DNA gave PCR products of identical size. As a control the same RNA sample was used to prepare cDNA subtending the intron of the PfDNA Pola gene (18) . PCR products generated from this cDNA and from genomic DNA using the appropriate flanking oligonucleotide primers gave evidence of intron removal as expected (Fig. 3) .
Chromosomal location and transcript size Pulsed field gel electrophoresis was used to separate the chromosomes of the parasite and blots were prepared and probed with a random-labelled 0.77kb BamHIIHindlI fragment from the 3' end of clone pUC3/1. The gene is located on chromosome 14 and this was confirmed by stripping the blot and reprobing with the chromosome 14 marker aldolase (39) (Fig. 4) . Southern blot analyses suggest that the gene is present as a single copy (data not shown).
The same labelled fragment was used to probe a blot of poly(A)+RNA prepared from unsynchronised cultured parasites. between open reading frame and corresponding message have been noted in the case of PCNA (17) and DNA Polb (16) .
Use of antibodies in Western blots and immunofluorescence assays Two separate antisera were raised. In both cases they recognised fusion protein in E.coli extracts strongly but showed a weak response towards GST. The latter was completely abolished by preadsorbing the antisera with immobilised GST. The reaction of the preadsorbed antisera with fusion protein was unchanged. We therefore believe the antisera are recognising topoisomerase II epitopes in the fusion protein. Both antisera revealed several weak bands in blots of size-fractionated parasite proteins. Although these did not always correspond in size, both antisera detected a weak band at about 160kDa, the anticipated size of Pftopoisomerase II (data not shown). The same antisera were used to probe fixed parasites in order to try and locate topoisomerase II within the cell and to determine when it appears during the intraerythrocytic development of the parasite.
Synchronised and unsynchronised material was used to do this. Synchronisation was achieved using two sequential sorbitol treatments separated by 16 hours. Immediately following the second sorbitol synchronisation most parasites appeared, as expected, as ring forms. Eight hours afterwards, trophozoites had increased to approximately 80% of the intraerythrocytic forms. In this synchronised sample the increase in schizonts was slightly delayed, taking place at between 20 and 24 hours after the second synchronisation (between 36 and 40hr post invasion). Both antisera stained the parasites at all stages in their development. The same result was obtained from nonsynchronised material. No obvious difference existed in the intensity of the fluorescence at different stages of development. The observations suggest that the antigen distribution coincides with the bodies staining with DAPI (see Fig. 5 ) and we propose that Pftopoisomerase 11 is present in the nuclei of the parasite at all stages of its intraerythrocytic development.
DISCUSSION
We have described an open reading frame which encodes a polypeptide with all the features of a type II DNA topoisomerase. The sequence appears to be present as a single copy located on chromosome 14 of strain Kl and we believe it to be the gene for the malarial homologue of the enzyme. Immunological evidence provides some support for this conclusion. Two independent antisera, produced by mice inoculated with recombinant GST fused to an amino terminal fragment of the putative DNA topoisomerase 11, recognised a protein of the expected size in western blots of whole parasite extracts. Immunofluorescence studies show that they also bind to a protein which appears to be located mainly in the parasite nucleus is the result of two asparagine-rich insertions which are present
